Four Berlin institutions, the Freie Universität Berlin, Humboldt-Universität zu Berlin, Technische Universität Berlin, the Charité – Universitätsmedizin Berlin, and the University of Oxford, have set out to create a new partnership which will open up…
TissUse and Roche have signed a cooperating agreement to develop human-relevant in vitro assays based on TissUse’s Multi-Organ-Chip technology.
Berlin is the new startup hub in Europe
New ERC-funded project at Charité to combine EEG data and machine learning
In the development of new medications and medical engineering, there is a gap between the discovery of new potential active ingredients and products and their further development into medicinal products and medical devices by the industry. The…
European Clusters are audited as part of the European Cluster Excellence Initiative (ECEI), and receive excellence labels in one of three stages based on set benchmarks: bronze, silver, and gold. Over 950 Clusters in all industries have already…
Dr. Viola Bronsema has been Managing Director of Biotechnologie-Industrie-Organisation (BIO) Deutschland e.V. in Berlin since October 2006. Previously, the biologist was head of communications at Roche Diagnostics GmbH and Diagnostics EMEA in…
Call ID: H2020-JTI-IMI2-2018-14-two-stage
Action Type: RIA – Research and Innovation Actions
Topics
. Berlin-based Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), a specialist in in isotope-related applications in medicine, science and industry, was able to push profits and net liquidity to new records in the 2017 fiscal…
NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX), the “Company”, a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), announced today that it has renegotiated and signed an amendment to its…
